A Phase I Dose-Escalation Study of a Biosimilar Trastuzumab in Chinese Metastasis Breast Cancer Patients
SpringerPlus - Germany
doi 10.1186/s40064-015-1603-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2015
Authors
Publisher
Springer Science and Business Media LLC